Cargando…

A mycobacterial growth inhibition assay (MGIA) for bovine TB vaccine development

Human tuberculosis remains a significant cause of mortality and morbidity throughout the world. The global economic impact of bovine TB is considerable. An effective vaccine would be the most cost-effective way to control both epidemics, particularly in emerging economies. TB vaccine research would...

Descripción completa

Detalles Bibliográficos
Autores principales:	Pepponi, Ilaria, Khatri, Bhagwati, Tanner, Rachel, Villarreal-Ramos, Bernardo, Vordermeier, Martin, McShane, Helen
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Churchill Livingstone 2017
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5670120/ https://www.ncbi.nlm.nih.gov/pubmed/28802398 http://dx.doi.org/10.1016/j.tube.2017.07.008

Ejemplares similares

The Cross-Species Mycobacterial Growth Inhibition Assay (MGIA) Project, 2010–2014
por: Brennan, Michael J., et al.
Publicado: (2017)

The in vitro direct mycobacterial growth inhibition assay (MGIA) for the early evaluation of TB vaccine candidates and assessment of protective immunity: a protocol for non-human primate cells
por: Tanner, Rachel, et al.
Publicado: (2021)

The Humoral Immune Response to BCG Vaccination
por: Tanner, Rachel, et al.
Publicado: (2019)

A new tool for tuberculosis vaccine screening: Ex vivo Mycobacterial Growth Inhibition Assay indicates BCG-mediated protection in a murine model of tuberculosis
por: Zelmer, Andrea, et al.
Publicado: (2016)

Tools for Assessing the Protective Efficacy of TB Vaccines in Humans: in vitro Mycobacterial Growth Inhibition Predicts Outcome of in vivo Mycobacterial Infection
por: Tanner, Rachel, et al.
Publicado: (2020)

Mycobacterial Growth Inhibition Assay (MGIA) as a Host Directed Diagnostic Tool for the Evaluation of the Immune Response in Subjects Living With Type 2 Diabetes Mellitus
por: Bobadilla-del-Valle, Miriam, et al.
Publicado: (2021)

Development of a BCG challenge model for the testing of vaccine candidates against tuberculosis in cattle
por: Villarreal-Ramos, Bernardo, et al.
Publicado: (2014)

Towards new TB vaccines
por: Brazier, Benedict, et al.
Publicado: (2020)

The influence of haemoglobin and iron on in vitro mycobacterial growth inhibition assays
por: Tanner, Rachel, et al.
Publicado: (2017)

A non-human primate in vitro functional assay for the early evaluation of TB vaccine candidates
por: Tanner, Rachel, et al.
Publicado: (2021)

Author Correction: The influence of haemoglobin and iron on in vitro mycobacterial growth inhibition assays
por: Tanner, Rachel, et al.
Publicado: (2019)

Development of an Antibody to Bovine IL-2 Reveals Multifunctional CD4 T(EM) Cells in Cattle Naturally Infected with Bovine Tuberculosis
por: Whelan, Adam O., et al.
Publicado: (2011)

Aerosol immunisation for TB: matching route of vaccination to route of infection
por: Manjaly Thomas, Zita-Rose, et al.
Publicado: (2015)

TB vaccine development: where are we and why is it so difficult?
por: Wilkie, Morven E M, et al.
Publicado: (2015)

A review of clinical models for the evaluation of human TB vaccines
por: O'Shea, Matthew K., et al.
Publicado: (2016)

Optimisation, harmonisation and standardisation of the direct mycobacterial growth inhibition assay using cryopreserved human peripheral blood mononuclear cells
por: Tanner, Rachel, et al.
Publicado: (2019)

Global Gene Transcriptome Analysis in Vaccinated Cattle Revealed a Dominant Role of IL-22 for Protection against Bovine Tuberculosis
por: Bhuju, Sabin, et al.
Publicado: (2012)

Progress and challenges in TB vaccine development
por: Voss, Gerald, et al.
Publicado: (2018)

A review of preclinical animal models utilised for TB vaccine evaluation in the context of recent human efficacy data()
por: McShane, Helen, et al.
Publicado: (2014)

Protection associated with a TB vaccine is linked to increased frequency of Ag85A-specific CD4(+) T cells but no increase in avidity for Ag85A
por: Metcalfe, Hannah J., et al.
Publicado: (2016)

Ag85A-specific CD4(+) T cell lines derived after boosting BCG-vaccinated cattle with Ad5-85A possess both mycobacterial growth inhibition and anti-inflammatory properties
por: Metcalfe, Hannah J., et al.
Publicado: (2018)

A Multi-Antigenic Adenoviral-Vectored Vaccine Improves BCG-Induced Protection of Goats against Pulmonary Tuberculosis Infection and Prevents Disease Progression
por: Pérez de Val, Bernat, et al.
Publicado: (2013)

Comparing the safety and immunogenicity of a candidate TB vaccine MVA85A administered by intramuscular and intradermal delivery()
por: Meyer, Joel, et al.
Publicado: (2013)

Using an effective TB vaccination regimen to identify immune responses associated with protection in the murine model
por: Pinpathomrat, Nawamin, et al.
Publicado: (2021)

Distinct Transcriptional and Anti-Mycobacterial Profiles of Peripheral Blood Monocytes Dependent on the Ratio of Monocytes: Lymphocytes
por: Naranbhai, Vivek, et al.
Publicado: (2015)

Optimisation of a functional mycobacterial growth-inhibition assay to improve its suitability for infant TB vaccine studies()
por: Burl, S., et al.
Publicado: (2013)

Regulation of mycobacterial infection by macrophage Gch1 and tetrahydrobiopterin
por: McNeill, Eileen, et al.
Publicado: (2018)

Preclinical Development of an In Vivo BCG Challenge Model for Testing Candidate TB Vaccine Efficacy
por: Minassian, Angela M., et al.
Publicado: (2011)

Development of a diagnostic compatible BCG vaccine against Bovine tuberculosis
por: Chandran, Aneesh, et al.
Publicado: (2019)

Transcriptional Profiling of Disease-Induced Host Responses in Bovine Tuberculosis and the Identification of Potential Diagnostic Biomarkers
por: Aranday-Cortes, Elihu, et al.
Publicado: (2012)

Adaption of the ex vivo mycobacterial growth inhibition assay for use with murine lung cells
por: Painter, Hannah, et al.
Publicado: (2020)

Immunological correlates of mycobacterial growth inhibition describe a spectrum of tuberculosis infection
por: O’Shea, Matthew K., et al.
Publicado: (2018)

Safety and Immunogenicity of Boosting BCG Vaccinated Subjects with BCG: Comparison with Boosting with a New TB Vaccine, MVA85A
por: Whelan, Kathryn T., et al.
Publicado: (2009)

Effect of vaccine dose on the safety and immunogenicity of a candidate TB vaccine, MVA85A, in BCG vaccinated UK adults
por: Pathan, Ansar A., et al.
Publicado: (2012)

Perspectives on the History of Bovine TB and the Role of Tuberculin in Bovine TB Eradication
por: Good, Margaret, et al.
Publicado: (2011)

Engineering new mycobacterial vaccine design for HIV–TB pediatric vaccine vectored by lysine auxotroph of BCG
por: Saubi, Narcís, et al.
Publicado: (2014)

Association of Human Antibodies to Arabinomannan With Enhanced Mycobacterial Opsonophagocytosis and Intracellular Growth Reduction
por: Chen, Tingting, et al.
Publicado: (2016)

Correction: Safety and Immunogenicity of Boosting BCG Vaccinated Subjects with BCG: Comparison with Boosting with a New TB Vaccine, MVA85A
por: Whelan, Kathryn T., et al.
Publicado: (2011)

Gene Expression and Cytokine Profile Correlate With Mycobacterial Growth in a Human BCG Challenge Model
por: Matsumiya, Magali, et al.
Publicado: (2015)

In vitro Mycobacterial Growth Inhibition in South Korean Adults With Latent TB Infection
por: Lee, Hyejon, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_ohmcoao0br6m97660820uenlg0